Trademarks = 8

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Frank Wu (4 out of 14 patents)

Zhonghui Wan (3 out of 3 patents)

Lin Li (2 out of 4 patents)

4. Rongyao Chen (2 out of 2 patents)

5. Lin Li (1 out of 4 patents)

6. Peng Peng (1 out of 1 patent)

7. Xiaoyan Qiang (1 out of 1 patent)

8. Zejuan Sheng (1 out of 1 patent)

9. Sishun Kang (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12751957 - Use of multikinase inhibitor (2026-10-06),

2. 12643898 - Method for synthesizing anti-tumor compound and intermediates thereof (2026-06-02),

3. 12465601 - Uses of phosphodiesterase inhibitors (2025-11-11),

4. 12371432 - Haloallylamine compounds and application thereof (2025-07-29),

5. 12291534 - Aminonorbornane derivative and manufacture method therefor and use thereof (2025-05-06),

6. 12234233 - Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof (2025-02-25),

7. 11718620 - Method for treating a cancer mediated by abnormality of multi-kinases (2023-08-08),

8. 11420975 - Substituted imidazo[1,5-a]pyrazines as Bruton's tyrosine kinase inhibitors (2022-08-23),

Company Overview

Transthera Sciences (Nanjing), Inc. is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The company specializes in the research and development of novel drug candidates targeting various diseases, leveraging advanced technologies and scientific expertise. With a commitment to improving patient outcomes, Transthera aims to bring transformative treatments to market through rigorous clinical trials and collaborations with healthcare professionals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#81 in Jiangsu

#3,464 in China

Jiangsu, China

Transthera Sciences (Nanjing), Inc.

Forward Citations = 1

9 inventors:

Frank Wu (4 out of 14 patents)

Zhonghui Wan (3 out of 3 patents)

Lin Li (2 out of 4 patents)

4. Rongyao Chen (2 out of 2 patents)

5. Lin Li (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Transthera Sciences (Nanjing), Inc.. Retrieved from https://idiyas.com/company/transthera-sciences-nanjing

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]